Periscope Capital’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.17M Sell
300,000
-100,090
-25% -$1.05M 0.35% 89
2025
Q4
$4.19M Hold
400,090
0.48% 46
2025
Q3
$4.14M Buy
400,090
+200,090
+100% +$2.07M 0.66% 47
2025
Q2
$2.06M Hold
200,000
0.45% 71
2025
Q1
$2.02M Buy
+200,000
New +$2.01M 0.87% 45

Other funds holding TDAC

Periscope Capital's TDAC Position: Q1 2026 in Review

Periscope Capital reduced its Translational Development Acquisition Corp (TDAC) stake by 25% in Q1 2026, selling an estimated $1.05M and leaving 300,000 shares worth $3.17M. The position accounts for 0.35% of the portfolio, ranked #89.

Periscope Capital first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $4.19M in Q4 2025. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Periscope Capital held 300,000 shares of Translational Development Acquisition Corp worth $3.17M as of Q1 2026.
  • Periscope Capital sold 100,090 Translational Development Acquisition Corp shares in Q1 2026, an estimated $1.05M.
  • Translational Development Acquisition Corp made up 0.35% of Periscope Capital's portfolio in Q1 2026, its #89 holding.
  • Periscope Capital first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • Periscope Capital's Translational Development Acquisition Corp position peaked at $4.19M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.